Liu, Jin
Lu, Jing
Qiang, Wanting
Jia, Yanchun
He, Haiyan
Ye, Xiaofei
Chng, Wee Joo http://orcid.org/0000-0003-2578-8335
Gale, Robert Peter
Liang, Yang http://orcid.org/0000-0002-4226-9580
Hou, Jian http://orcid.org/0000-0002-2813-5850
Du, Juan http://orcid.org/0000-0003-2538-4007
Funding for this research was provided by:
National Natural Science Foundation of China (82170198, 81870164)
Article History
Received: 13 September 2022
Revised: 22 November 2022
Accepted: 23 November 2022
First Online: 6 December 2022
Competing interests
: RPG is a consultant to NexImmune Inc. Nanexa Pharma Ascentage Pharm Group and Antengene Biotech LLC, Medical Director of FFF Enterprises Inc.; Partner in AZAC Inc.; Board of Directors of Russian Foundation for Cancer Research Support and Scientific Advisory Board: StemRad Ltd.